Css LLC Neurocrine Biosciences Inc Transaction History
Css LLC
- $1.04 Billion
- Q4 2024
A detailed history of Css LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Css LLC holds 5,000 shares of NBIX stock, worth $569,850. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,000Holding current value
$569,850% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NBIX
# of Institutions
652Shares Held
96.5MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.62 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.15 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$557 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$344 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$289 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...